Immunoglobulin G4-related disease (IgG4-RD), which affects many organ systems, has been recognized as a distinct clinical entity in human medicine for just over a decade but has not been previously identified in dogs. In humans, IgG4-RD is characterized by diffuse IgG4-positive lymphoplasmacytic infiltrates that commonly lead to increased serum concentrations of IgG4 and IgE, peripheral eosinophilia, tumorous swellings that often include the parotid salivary glands, obliterative phlebitis, and extensive fibrosis. Herein we describe the diagnosis, clinical progression, and successful treatment of IgG4-RD in an 8-year-old female spayed Husky mixed breed dog.
| CASE PRESENTATION
An 8 year old female spayed Husky mixed breed dog initially was presented to the primary care veterinarian for evaluation of lethargy, mild hyporexia, intermittent soft feces, vomiting, and coughing. Physical examination at that time disclosed a mildly thin body condition and lowgrade periodontal disease, but no other clinically relevant abnormalities.
Thoracic auscultation was normal, the abdomen was soft and nonpainful, and no orthopedic or neurological abnormalities were noted. Serum capillary zone protein electrophoresis (CZE, Sebia Capillarys 2 Flex Piercing, see Supporting Information) identified a large spike in the beta 2 -gamma globulin region, a second smaller amplitude peak in the cathodal end of the gamma globulin region and a broad betagamma peak that induced beta-gamma bridging ( Figure 1A ). The restricted pattern of migration and the magnitude of the spike raised suspicion for a monoclonal gammopathy in a polyclonal base. A urine protein electrophoresis (agarose gel electrophoresis, Sebia Hydrasys Abbreviations: AGE, agarose gel electrophoresis; CZE, capillary zone electrophoresis; IF, immunofixation; IMGT, Immunogenetics Information System; MCH, major histocompatibility; MUM1, multiple myeloma 1/interferon regulatory factor 4 protein; SPE, Serum Protein Electrophoresis; PARR, PCR for antigen receptor rearrangement; RI, reference interval.
System, see Supporting Information) also was performed. A broad band in the beta-globulin region that mirrored the large spike in the serum was observed and raised concern for monoclonal light chains (Figure 4 ).
| DISCUSSION
We are aware of a single case of suspected immunoglobulin G4-related disease (IgG4-RD) in a dog, which ultimately could not be confirmed. 3 It is unclear if any of the eosinophilic granuloma cases previously reported in Husky dogs share a common pathogenesis with IgG4-RD, but the cases do describe involvement of mass-like lesions around the head or abdominal organs, fibroplasia and lymphoplasmacytic inflammation. [4] [5] [6] Ours is the first reported case with clinical support for a diagnosis of IgG4-RD in a dog.
Because of the use of different evolving and mutually overlapping nomenclature systems, the literature and nomenclature on canine IgG subclasses can be confusing. [7] [8] [9] [10] We use the current International Immunogenetics Information System (IMGT) database nomenclature of IgG4 to refer to the IgG subclass identified by serum protein purification and DNA sequencing (accession number AF354267, initially named IgG-D). 9,10 Concurrently, a 2 subclass system is used for production of commercially available polyclonal IgG antibodies. 10, 11 The "anti-IgG1" and "anti-IgG2" antibodies from this system show variable cross-reactivity with fractions from the 4 subclass systems depending on the testing platform and system used and this 2 subclass system should not be considered congruent with IgG1 and IgG2 of the 4 subclass systems. 10, 11 Ultimately, human IgG4 and canine IgG4 display similar response to physiologic stimuli and binding to F c gamma receptors and are considered similar for the purposes of this work. [10] [11] [12] [13] [14] [15] Immunoglobulin G4-related disease was first described as a distinct entity in the human medical literature as a sclerosing (autoimmune) pancreatitis associated with IgG4 lymphoplasmacytic (IgG4-producing plasma cells) infiltration and fibrosis of the pancreas. 16 It subsequently has been identified in many organs, including pancreas, salivary gland, periorbital tissue, retroperitoneum, kidney, biliary tract, lungs, thyroid glands, and other organs. 17 Affected organs have non-neoplastic tumoral swellings characterized by a diffuse lymphoplasmacytic infiltrate with IgG4-positive plasma cells, extensive storiform fibrosis, and obliterative phlebitis. 17 Cases of IgG4-RD also have expanded populations of follicular T-helper cells, cytotoxic CD4+ T cells, IgG4-positive mast cells and clonal expansion of IgG4-producing plasma cells. 18, 19 Concurrent with organ involvement, diagnostically useful peripheral eosinophilia, increased serum IgE concentration, and increased polyclonal serum concentrations of IgG4 are commonly found. 17, 19 The IgG4 antibodies in affected human patients appear to target annexin A11 in an autoimmune manner, but the exact pathogenesis of the disease is uncertain because IgG4 typically is thought to have anti-inflammatory functions. 20 Other investigations indicate that IgG4-RD may be a paraneoplastic response. 21 Tumoral swellings in the parotid salivary gland developed weeks after documentation of a monoclonal gammopathy in our case and may represent a reactive process secondary to the underlying IgG4 disorder. The observed mass-like lesions were not histologically evalu- The initial serum protein electrophoresis identified a highconcentration and restricted protein band in the beta-gamma globulin region, which mimicked a monoclonal gammopathy. Immunoglobulin G4 typically is found in very low concentrations in health and may not be readily apparent on routine SPE of the dog. 11 In humans, increased concentrations of polyclonal IgG4 commonly are found as a restrictedappearing protein band by routine SPE that gives the appearance of a monoclonal protein. 22 High-concentration monoclonal gammopathies typically have a suppressive effect on non-neoplastic immunoglobulin concentrations. 23, 24 This results in a monoclonal peak standing within what would otherwise be considered hypogammaglobulinemia. This finding is in contrast with the broad polyclonal background of gamma globulins seen with restricted polyclonal gammopathies. 23, 24 The electrophoretic pattern of our case suggests a restricted polyclonal gammopathy.
The extended immunofixation panel used in our case identified the large beta-gamma peak as IgG4 and identified a polyclonal IgG response comprised of other IgG subclasses. Although IF does not allow direct quantification, correlation with the electrophoretogram can inform a semiquantitative assessment of protein abundance. In our case, it suggests a substantial component of IgG4, which resolved with treatment. A markedly increased IgG4 fraction is thought to be common in humans with IgG4-RD, but is variable and may be present in only 51% of cases. 17, 25 Canine IgG4 ELISA assays have been developed using either monoclonal or polyclonal reagents, but these are no longer available. 11, 26, 27 Although IF can be used to suggest the presence of increased amounts of IgG4, re-institution of an ELISA assay for IgG4 may facilitate diagnosis of future cases of IgG4-RD.
Human patients with IgG4-RD typically are highly responsive to glucocorticoids, if treatment is initiated before the onset of substantial fibrosis. 28 Treatment is expected to include both resolution of masslike lesions and a decrease in serum IgG4 concentration, but, serum IgG4 concentrations can remain high after treatment. 25 Recrudescence of disease is expected in affected humans but has not been observed in our case, at the time of writing. 17, 25, 28 Monitoring serum IgE and IgG4 concentrations has been proposed to help predict disease relapse in affected human patients and could be attempted in affected dogs. 19 The clinical findings and response to treatment in our case support a diagnosis of IgG4-RD. The mass-like lesions, plasmacytosis, and marked hyperglobulinemia with restricted polyclonal gammopathy, which could be interpreted as a monoclonal gammopathy all raised concern for an immunoglobulin-secreting neoplasm. Previous cases of IgG4-RD in dogs may have been misclassified as a neoplastic process, as has been documented in human medicine. Clinical awareness of this disease entity in the dog as a differential diagnosis is important when evaluating patients with possible monoclonal gammopathy, plasmacytosis, and eosinophilia.
